DK3340968T3 - Implanterbare naltrexon-tabletter - Google Patents
Implanterbare naltrexon-tabletter Download PDFInfo
- Publication number
- DK3340968T3 DK3340968T3 DK16838697.7T DK16838697T DK3340968T3 DK 3340968 T3 DK3340968 T3 DK 3340968T3 DK 16838697 T DK16838697 T DK 16838697T DK 3340968 T3 DK3340968 T3 DK 3340968T3
- Authority
- DK
- Denmark
- Prior art keywords
- naltrexone tablets
- implantable
- implantable naltrexone
- tablets
- naltrexone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3223MU2015 | 2015-08-24 | ||
| PCT/IN2016/050280 WO2017033208A2 (en) | 2015-08-24 | 2016-08-23 | Implantable naltrexone tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3340968T3 true DK3340968T3 (da) | 2022-08-29 |
Family
ID=58100015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16838697.7T DK3340968T3 (da) | 2015-08-24 | 2016-08-23 | Implanterbare naltrexon-tabletter |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10507184B2 (da) |
| EP (1) | EP3340968B1 (da) |
| CA (1) | CA2994212A1 (da) |
| DK (1) | DK3340968T3 (da) |
| ES (1) | ES2925727T3 (da) |
| HR (1) | HRP20220922T1 (da) |
| HU (1) | HUE059548T2 (da) |
| LT (1) | LT3340968T (da) |
| PL (1) | PL3340968T3 (da) |
| PT (1) | PT3340968T (da) |
| SI (1) | SI3340968T1 (da) |
| WO (1) | WO2017033208A2 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11185540B2 (en) | 2017-04-12 | 2021-11-30 | Pardon My Scotch Llc. | Extended release compositions of opioid antagonists and phosphodiesterase 5 inhibitors |
| CA3077698A1 (en) * | 2017-10-02 | 2019-04-11 | BioCorRx Inc. | Subcutaneous biodegradable naltrexone implant and accompanying behavioral program for weight loss in a patient |
| US10807995B2 (en) | 2018-07-13 | 2020-10-20 | Alkermes Pharma Ireland Limited | Thienothiophene compounds for long-acting injectable compositions and related methods |
| US10799496B2 (en) | 2018-07-13 | 2020-10-13 | Alkermes Pharma Ireland Limited | Naphthylenyl compounds for long-acting injectable compositions and related methods |
| AU2019362730B2 (en) | 2018-10-15 | 2022-10-20 | Chong Kun Dang Pharmaceutical Corp. | Injectable long-acting naltrexone microparticle compositions |
| US10975099B2 (en) | 2018-11-05 | 2021-04-13 | Alkermes Pharma Ireland Limited | Thiophene compounds for long-acting injectable compositions and related methods |
| WO2021041740A1 (en) * | 2019-08-28 | 2021-03-04 | Delpor, Inc. | Compositions of opioid antagonists, implant devices, and treatment methods for opioid use disorder |
| US20210059943A1 (en) * | 2019-09-04 | 2021-03-04 | Buffalo Pacific LLC | Systems and methods addressing multiple aspects to provide a comprehensive recovery program for addictions, chronic conditions and diseases |
| US20240050448A1 (en) * | 2020-12-30 | 2024-02-15 | Biocorrx, Inc. | Biodegradable Implant Including Naltrexone and Cholesterol |
| US11197819B1 (en) * | 2021-04-09 | 2021-12-14 | Drug Delivery Company, Llc | Extended release bioabsorbable subcutaneous medicinal dosage delivery implant system |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3710175A1 (de) * | 1987-02-12 | 1988-08-25 | Hoechst Ag | Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung |
| US6203813B1 (en) * | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
| CN102871979B (zh) * | 2000-09-01 | 2014-10-22 | 帕尔马亚有限公司 | 缓释药物制剂及其施用方法 |
| WO2004096201A1 (en) * | 2003-04-29 | 2004-11-11 | Orexigen Therapeutics, Inc. | Compositions for affecting weight loss |
| US20090208540A1 (en) * | 2003-08-11 | 2009-08-20 | Indevus Pharmaceuticals, Inc. | Implantable device for the delivery of naltrexone and methods of use thereof |
| CN100379420C (zh) * | 2006-09-19 | 2008-04-09 | 深圳市思沃生命科学技术有限公司 | 一种用于戒毒的长效缓释制剂及其制备方法和用途 |
| CN101700226A (zh) * | 2009-03-26 | 2010-05-05 | 海南凤凰国际药物研究院 | 一种不需要包衣的纳曲酮长效缓释制剂及其制备方法 |
| WO2010151741A1 (en) * | 2009-06-25 | 2010-12-29 | Elite Laboratories, Inc. | Abuse resistant oral dosage forms |
| CN102512399B (zh) * | 2011-12-31 | 2013-05-01 | 湖南赛沃药业股份有限公司 | 一种长效纳曲酮植入剂及其制备方法 |
| RU2476209C1 (ru) * | 2012-02-29 | 2013-02-27 | Станислав Анатольевич Кедик | Имплантируемое лекарственное средство на основе налтрексона для лечения пациентов, зависимых от алкоголя или опиатов |
-
2016
- 2016-08-23 HR HRP20220922TT patent/HRP20220922T1/hr unknown
- 2016-08-23 ES ES16838697T patent/ES2925727T3/es active Active
- 2016-08-23 SI SI201631578T patent/SI3340968T1/sl unknown
- 2016-08-23 PL PL16838697.7T patent/PL3340968T3/pl unknown
- 2016-08-23 WO PCT/IN2016/050280 patent/WO2017033208A2/en active Application Filing
- 2016-08-23 DK DK16838697.7T patent/DK3340968T3/da active
- 2016-08-23 HU HUE16838697A patent/HUE059548T2/hu unknown
- 2016-08-23 EP EP16838697.7A patent/EP3340968B1/en active Active
- 2016-08-23 PT PT168386977T patent/PT3340968T/pt unknown
- 2016-08-23 LT LTEPPCT/IN2016/050280T patent/LT3340968T/lt unknown
- 2016-08-23 US US15/755,374 patent/US10507184B2/en not_active Expired - Fee Related
- 2016-08-23 CA CA2994212A patent/CA2994212A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT3340968T (pt) | 2022-07-05 |
| LT3340968T (lt) | 2022-09-12 |
| ES2925727T3 (es) | 2022-10-19 |
| EP3340968A4 (en) | 2019-03-27 |
| US10507184B2 (en) | 2019-12-17 |
| PL3340968T3 (pl) | 2022-09-26 |
| HUE059548T2 (hu) | 2022-11-28 |
| EP3340968B1 (en) | 2022-06-01 |
| WO2017033208A3 (en) | 2017-05-04 |
| WO2017033208A2 (en) | 2017-03-02 |
| HRP20220922T1 (hr) | 2022-10-28 |
| CA2994212A1 (en) | 2017-03-02 |
| EP3340968A2 (en) | 2018-07-04 |
| SI3340968T1 (sl) | 2022-10-28 |
| US20180338925A1 (en) | 2018-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3310231T3 (da) | Doseringsindretning | |
| DK3235465T3 (da) | Implantat | |
| DK3265421T3 (da) | Doseringssystem | |
| DK3340968T3 (da) | Implanterbare naltrexon-tabletter | |
| IL254818A0 (en) | Ribociclib tablet | |
| DK3204111T3 (da) | Implanterbar indretning | |
| DK3370641T3 (da) | Intraluminal anordning | |
| DK3199161T3 (da) | Farmaceutisk præparat | |
| HK1249857A1 (zh) | 片劑 | |
| KR20180084810A (ko) | 정제 세트 | |
| UA31197S (uk) | Таблетка | |
| MA42799A (fr) | Mini comprimés de palipéridone | |
| DK3288967T3 (da) | Farmaceutisk forbindelse | |
| EP3431079C0 (en) | COMPRESSED | |
| GB201511252D0 (en) | Tablet | |
| FI10942U1 (fi) | Koriste-elementti | |
| NO20141516A1 (no) | Plaster | |
| TWM532873U (en) | Tablet structure | |
| ITUA20162175A1 (it) | Stimolatore clitorideo | |
| DK3288966T3 (da) | Farmaceutisk forbindelse | |
| UA31602S (uk) | Логотип | |
| UA30919S (uk) | Логотип | |
| UA30918S (uk) | Логотип | |
| UA30346S (uk) | Логотип | |
| UA30461S (uk) | Логотип |